NCT00953914View on ClinicalTrials.gov

Pyridostigmine and Its Effects on Autonomic Modulation in Diabetic Patients

NACompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

March 31, 2005

Primary Completion Date

July 31, 2009

Study Completion Date

May 31, 2010

Conditions
Diabetes Complications
Interventions
DRUG

Pyridostigmine

Pills containing 30 mg of Pyridostigmine will be orally administered 3 times daily for 1 day.

DRUG

Placebo

If subject is randomized to placebo, placebo pills will give 30 mg orally 3 times daily for 2 days

Trial Locations (1)

Unknown

Hospital de Clínicas de Porto Alegre, Porto Alegre

All Listed Sponsors
lead

Hospital de Clinicas de Porto Alegre

OTHER

NCT00953914 - Pyridostigmine and Its Effects on Autonomic Modulation in Diabetic Patients | Biotech Hunter | Biotech Hunter